Literature DB >> 30033075

Author Response to Letter: Will increasing dosing intervals decrease the loss of anti-HPV seropositivity over time?

Lea E Widdice1, David I Bernstein2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30033075      PMCID： PMC6818497          DOI： 10.1016/j.vaccine.2018.03.089

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  5 in total

1.  Antibody persistence and evidence of immune memory at 5years following administration of the 9-valent HPV vaccine.

Authors:  Ana Guevara; Robinson Cabello; Linn Woelber; Edson Duarte Moreira; Elmar Joura; Olaf Reich; Christine Shields; Misoo C Ellison; Amita Joshi; Alain Luxembourg
Journal:  Vaccine       Date:  2017-08-05       Impact factor: 3.641

2.  4-Valent Human Papillomavirus (4vHPV) Vaccine in Preadolescents and Adolescents After 10 Years.

Authors:  Daron G Ferris; Rudiwilai Samakoses; Stanley L Block; Eduardo Lazcano-Ponce; Jaime Alberto Restrepo; Jesper Mehlsen; Archana Chatterjee; Ole-Erik Iversen; Amita Joshi; Jian-Li Chu; Andrea Likos Krick; Alfred Saah; Rituparna Das
Journal:  Pediatrics       Date:  2017-12       Impact factor: 7.124

3.  The humoral response to Gardasil over four years as defined by total IgG and competitive Luminex immunoassay.

Authors:  Darron R Brown; Suzanne M Garland; Daron G Ferris; Elmar Joura; Marc Steben; Margaret James; David Radley; Scott Vuocolo; Elizabeth I O Garner; Richard M Haupt; Janine T Bryan
Journal:  Hum Vaccin       Date:  2011-02-01

4.  Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.

Authors:  Sven-Eric Olsson; Luisa L Villa; Ronaldo L R Costa; Carlos A Petta; Rosires P Andrade; Christian Malm; Ole-Erik Iversen; John Høye; Margareta Steinwall; Grete Riis-Johannessen; Agneta Andersson-Ellstrom; Kristina Elfgren; Geo von Krogh; Matti Lehtinen; Jorma Paavonen; Gretchen M Tamms; Katherine Giacoletti; Lisa Lupinacci; Mark T Esser; Scott C Vuocolo; Alfred J Saah; Eliav Barr
Journal:  Vaccine       Date:  2007-04-20       Impact factor: 3.641

5.  High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up.

Authors:  L L Villa; R L R Costa; C A Petta; R P Andrade; J Paavonen; O-E Iversen; S-E Olsson; J Høye; M Steinwall; G Riis-Johannessen; A Andersson-Ellstrom; K Elfgren; G von Krogh; M Lehtinen; C Malm; G M Tamms; K Giacoletti; L Lupinacci; R Railkar; F J Taddeo; J Bryan; M T Esser; H L Sings; A J Saah; E Barr
Journal:  Br J Cancer       Date:  2006-11-21       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.